Cargando…
Can Molecular Biomarkers Change the Paradigm of Pancreatic Cancer Prognosis?
Pancreatic ductal adenocarcinoma is one of the most lethal types of tumour, and its incidence is rising worldwide. Although survival can be improved when these tumours are detected at an early stage, this cancer is usually asymptomatic, and the disease only becomes apparent after metastasis. The onl...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi Publishing Corporation
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023838/ https://www.ncbi.nlm.nih.gov/pubmed/27689078 http://dx.doi.org/10.1155/2016/4873089 |